Press release
Diabetes Care Drugs Market Size to Reach $90.50 Billion by 2029 | Growth at 5.3% CAGR Forecast
Diabetes Care Drugs
What is the Projected Market Size of the Diabetes Care Drugs Industry?
In recent times, the market size for diabetes care drugs has seen substantial growth. It is projected to increase from $69.55 billion in 2024 to $73.48 billion in 2025 with a compound annual growth rate (CAGR) of 5.6%. The historical growth in this market is directly related to various factors such as the global increase in diabetes cases, an aging population, sedentary and unhealthy lifestyle choices, escalating obesity rates, and the expanding use of personalized medicine.
What Will Be the Size of the Diabetes Care Drugs Market by 2029?
In the forthcoming years, the diabetes care drugs market is projected to experience robust growth, escalating to $90.50 billion in 2029 with a compound annual growth rate (CAGR) of 5.3%. This growth during the prediction period can be credited to the rise of biosimilar insulins, the advancement of combination therapies, and fixed-dose formulations. Moreover, the escalating concentration on continuous glucose monitoring and closed-loop systems, as well as burgeoning awareness and prevention programs focussed on prediabetes also contribute. Noteworthy trends in the forecast period incorporate the addition of continuous glucose monitoring with smart drug delivery, the uptake of digital patient engagement platforms, wearable drug delivery gadgets, progression in peptide or polymer-based sustained-release formulations, and the fusion of pharmacogenomics for tailored dosing.
Explore The Complete Report Now:
https://www.thebusinessresearchcompany.com/report/diabetes-care-drugs-global-market-report
What Are the Key Drivers Accelerating Growth in the Diabetes Care Drugs Market?
The diabetes care drugs market is set to experience expansion due to the rising prevalence of diabetes mellitus patients. These patients have a long-term health condition which affects their body's ability to process blood sugar or glucose. The increase in diabetic patients can be attributed to poor eating habits and sedentary lifestyles, as they contribute to obesity and insulin resistance. Drugs intended for diabetes care are critical in managing blood glucose levels effectively, thereby mitigating risks associated with type 1 and type 2 diabetes. These drugs are capable of steadying sugar levels, enhancing a patient's overall health, as well as significantly improving their quality of life. For example, the National Health Service, a government department based in the UK, revealed in June 2024 that 3,615,330 individuals who had registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023, a substantial 18% increase from the 3,065,825 cases in 2022. Hence, an upward surge in the number of diabetic patients is catalyzing the growth of the diabetes care drugs market.
Get Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25748&type=smp
How Is the Diabetes Care Drugs Market Segmented by Type, Application, and Region?
The diabetes care drugs market covered in this report is segmented -
1) By Drug Class: Insulin, Biguanides, Sulfonylureas, Dipeptidyl Peptidase (DPP)-4 Inhibitors, Sodium-Glucose Co-Transporter (SGLT)-2 Inhibitors, Glucagon-Like Peptide (GLP)-1 Receptor Agonists, Thiazolidinediones, Alpha-Glucosidase Inhibitors
2) By Formulation Type: Tablets, Injections, Solutions, Gels, Extended-Release Formulations
3) By Administration Route: Oral, Injectable, Inhalable
4) By Condition: Diabetes Type 1, Diabetes Type 2
5) By Distribution Channel: Hospital Pharmacies, Specialty Pharmacies
Subsegments:
1) By Insulin: Rapid-acting insulin, Short-acting insulin, Intermediate-acting insulin, Long-acting insulin, Pre-mixed insulin
2) By Biguanides: Metformin Immediate Release (IR), Metformin Extended Release (ER)
3) By Sulfonylureas: First-generation sulfonylureas, Second-generation sulfonylureas
4) By Dipeptidyl Peptidase (DPP)-4 Inhibitors: Sitagliptin, Saxagliptin, Linagliptin, Alogliptin
5) By Sodium-Glucose Co-Transporter (SGLT)-2 Inhibitors: Canagliflozin, Dapagliflozin, Empagliflozin, Ertugliflozin
6) By Glucagon-Like Peptide (GLP)-1 Receptor Agonists: Exenatide, Liraglutide, Dulaglutide, Semaglutide, Lixisenatide
7) By Thiazolidinediones (TZDs): Pioglitazone, Rosiglitazone
8) By Alpha-Glucosidase Inhibitors: Acarbose, Miglitol
What Are the Key Trends Driving Growth in the Diabetes Care Drugs Market?
Leading corporations in the diabetes care drugs market are aiming their sights on the creation of innovative treatments such as fixed-ratio combination therapies. These therapies are projected to help enhance glycemic control, encourage patient compliance, and consolidate treatment plans. Fixed-ratio combination therapies are medications that blend two antidiabetic components into a single injection, making diabetes management more effective and straightforward. In April 2024, a milestone was marked by Sanofi SA, a pharmaceutical firm based in France. They introduced Soliqua, a unique once-daily fixed-ratio combination of insulin glargine and lixisenatide, specifically engineered for adult patients with the onus of type 2 diabetes and obesity. Soliqua is a mixture of long-acting insulin glargine, which supports constant fasting glucose control, and lixisenatide, which is a GLP-1 receptor agonist. This drop combines to enhance the secretion of insulin dependent on glucose levels, suppress the production of glucagon, and slow down gastric emptying to lessen post-meal blood sugar levels, thereby offering an all-inclusive daily glycemic management solution. The introduction of Soliqua simplifies diabetes management, betters glycemic control and boosts patient compliance by mitigating the necessity for multiple daily injections and reducing potential side effects such as hypoglycemia and weight gain.
Customize Your Insights And Get The Full Report Here:
https://www.thebusinessresearchcompany.com/customise?id=25748&type=smp
Who Are the Leading Companies Driving Growth in the Diabetes Care Drugs Market?
Major companies operating in the diabetes care drugs market are Johnson & Johnson, Merck & Co. Inc., Bayer AG, Sanofi S.A., Bristol‐Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, GSK plc, Medtronic plc, Eli Lilly and Company, Teva Pharmaceuticals Limited, Astellas Pharma Inc., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Dr. Reddy's Laboratories, Cipla Limited, Lupin Limited, Takeda Pharmaceutical Company Limited, Biocon Limited, Glenmark Pharmaceuticals Limited, Insulet Corporation, Torrent Pharmaceuticals Ltd., Hanmi Pharmaceutical Limited, Hualan Biological, Wockhardt, Mitsubishi Tanabe Pharma, Gan & Lee Pharmaceuticals, DiogenX, Oramed Pharmaceuticals, Apotex.
Which Is the Leading Region in the Global Diabetes Care Drugs Market?
North America was the largest region in the diabetes care drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the diabetes care drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Speak With Our Expert: Saumya Sahay: Americas +1 310-496-7795: Asia +44 7882 955267 & +91 8897263534: Europe +44 7882 955267: Email: saumyas@tbrc.info: The Business Research Company - www.thebusinessresearchcompany.com: Follow Us On: LinkedIn: https://in.linkedin.com/company/the-business-research-company
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Diabetes Care Drugs Market Size to Reach $90.50 Billion by 2029 | Growth at 5.3% CAGR Forecast here
News-ID: 4157115 • Views: …
More Releases from The Business Research Company
Global Hexane Market Expansion at 7.6% CAGR, Valued at $3.31 Billion by 2029
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
What Are the Hexane Market Size Forecast for 2025?
Over the past few years, the hexane market has seen consistent growth. An escalation from $2.39 billion in 2024 to $2.47 billion in 2025, with a compound annual growth rate (CAGR) of 3.3%, is anticipated. The growth previously witnessed can be…
Gonadotropin-Releasing Hormone (GnRH) Receptor Antagonists Market to Record 8.5% …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Gonadotropin-Releasing Hormone (GnRH) Receptor Antagonists Market Outlook: How is the Market Expected to Grow by 2025?
The market size of gonadotropin-releasing hormone (GnRH) receptor antagonists has experienced significant growth in recent times. Predictions indicate a rise from $1.46 billion in 2024 to $1.59 billion in 2025, with an 8.8% compound…
Common Cold Industry Set to Achieve $34.30 Billion Milestone by 2029 | Steady 6. …
Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.
What Is the Long-Term Growth Forecast for the Common Cold Market Size 2025?
In the past few years, there has been a robust expansion in the market size of the common cold. It is forecasted to escalate from $25.22 billion in 2024 to $26.89 billion in 2025, with a compound annual growth…
Calcitonin Gene-Related Peptide Receptor Antagonist Market to Surpass $3.48 Bill …
Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.
How Will the Calcitonin Gene-Related Peptide Receptor Antagonist Market Grow by 2025 in Terms of Size and Growth?
The market size for calcitonin gene-related peptide receptor antagonists has been expanding swiftly in recent times. The projection is that it will increase from $2.06 billion in 2024 to $2.30 billion in 2025, representing…
More Releases for Diabetes
Major Force in the Diabetes Pen Market 2025: Diabetes Fuels Surge In Demand For …
How Will the Diabetes Pen Market Grow, and What Is the Projected Market Size?
The diabetes pen market is projected to grow from $29.24 billion in 2024 to $31.22 billion in 2025, at a CAGR of 6.8%. Growth is fueled by the rising need for managing diabetes, advancements in diabetes care, and an increasing focus on patient-friendly medication administration tools.
The diabetes pen market is projected to grow strongly, reaching $40.17 billion…
Diabetes Monitoring Devices Market: Regaining Its Glory| Ascensia Diabetes Care, …
The Latest Study Published by HTF MI Research on the "Diabetes Monitoring Devices Market'' evaluates market size, trend and forecast to 2029. The Diabetes Monitoring Devices market study includes significant research data and evidences to be a practical resource document for managers and analysts is, industry experts and other key people to have an easily accessible and self-analysed study to help understand market trends, growth drivers, opportunities and upcoming challenges…
Prevalence of Diabetes Drives Opportunities for Type-2 Diabetes Market
The Type-2 Diabetes Market Analysis, 2023, by MarkNtel Advisors, presents a well-researched, detail-driven, and accurate study for the stakeholders. This analysis entails prominent aspects like trends, & recent developments, drivers, opportunities, challenges, & restraints, among other parameters, influencing the overall industry expansion across different locations. This report comprises data from historic years (2018-21) & the base year (2022) to put together an estimation of the forecast period (2023-28).
According to Type-2 Diabetes Market…
Reverse Diabetes with Dr. Merritt’s Diabetes Reversal Recipe
[November 26, 2020] – People suffering from diabetes always search for ways to lower blood sugar levels in their bodies. Diabetes treatment available costs you hundreds of dollars yearly and also restricts you to a diabetic diet. That hampers your mental health and well-being. Apart from this, eye problems, kidney failure, amputations are some of the physical problems diabetic patients face.
Dr. Marlene Merritt (from the Merritt Wellness Center in…
Emerging trends for Diabetes Care Devices Market 2020 astonishing growth by Worl …
The global diabetes care devices market is expected to reach US$ 39,382.3 Mn in 2027 from US$ 23,354.3 Mn in 2018. The market is estimated to grow with a CAGR of 6.1% from 2020-2027.
Premium market insights recently published a report titled "Diabetes Care Devices Market Size and Forecast to 2026". The report includes an authentic and accurate research study into the global Diabetes Care Devices market based on a qualitative…
Diabetes Treatment
Diabetes Treatment is a important way to help manage the healthy ,easy to use and improve the way of the treatment of blood glucose monitoring system.
As living standards improve, an increasing obesity, the Diabetes Treatment has improved peoples living habits, disease control effect, is becoming more and more important.
The global Diabetes Treatment market is valued at 43700 million US$ in 2018 and will reach 58000 million US$ by the end…
